Subscription Model Gains Popularity, Offering Highly Personalized Genetic Solutions

DUBLIN, Oct. 27, 2023 /PRNewswire/ — The “US DTC Genetic Testing Market – Focused Insights 2023-2028” report has been added to  ResearchAndMarkets.com’s offering. Th US DTC Genetic testing market is projected to reach a value of $1.65 billion by 2028 from $890 million, growing at a CAGR of 10.8% Genetic testing is on the rise in … Read more

CONVENING NOTICE – EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)

LUND, SWEDEN, Oct. 27, 2023 /PRNewswire/ — Immunovia AB (publ), reg. no. 556730-4299 (the “Company“), hereby gives notice that an extraordinary general meeting will take place on Tuesday 21st November 2023 at 10.00 in the Company’s offices at Medicon Village, Scheeletorget 1, Lund. Registration to the extraordinary general meeting starts at 09:45.  Notice/Right to participate at … Read more

HARMONY BIOSCIENCES SHOWCASES THE NEWEST PATIENTS AT THE HEART AND PROGRESS AT THE HEART AWARD RECIPIENTS

PLYMOUTH MEETING, Pa., Oct. 26, 2023 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, has selected the latest round of nonprofit organizations for its Patients at the Heart and Progress at the Heart awards. These awards provide funding support … Read more

Leading Health Tech ŌURA and Cronometer Unlock A World Of Insights With New Menstrual Cycle Tracking Functionality

Building on the long-standing integration between the two apps, Cronometer has introduced a Cycle Tracking feature that leverages data from ŌURA’s new Cycle Insights functionality. Cronometer users with a menstrual cycle using the latest version of the app can now view cycle day, body temperature variation, and cycle phase (luteal or follicular) along with helpful information about … Read more

GELITA lanzará dos soluciones de ingredientes innovadoras en Supply Side West Expo

CIUDAD DE MEXICO, 24 de octubre de 2023 /PRNewswire/ — Como patrocinador oficial de colágeno de SupplySide West Expo (25 y 26 de octubre) en Las Vegas, el líder en innovación GELITA destacará su gama de soluciones de ingredientes para mejorar la calidad de vida y lanzará dos soluciones: productos farmacéuticos gelatina de grado EASYSEAL® … Read more

Medical equipment maintenance market size to increase by USD 39.28 billion | The product innovation and advances leading to portfolio extension and product premiumization drives the market growth

NEW YORK, Oct. 23, 2023 /PRNewswire/ — The Medical Equipment Maintenance Market by Type, End-user and Geography – Forecast and Analysis 2023-2027 report has been published by Technavio. Market size is forecast to grow by USD 39.28 billion between 2022 and 2027 at a CAGR of 12.01%. The report includes historic market data from 2017 to 2021. In … Read more

Michigan Medicine harnesses the power of Sectra’s digital pathology solution to enhance patient care and foster collaboration among physicians

LINKÖPING, Sweden and SHELTON, Conn., Oct. 23, 2023 /PRNewswire/ — International medical imaging IT and cybersecurity company Sectra (STO: SECT B) announces that the US health and academic center Michigan Medicine is expanding its usage of Sectra’s enterprise imaging solution by including Sectra’s module for digital pathology. This will enable their pathologists to review and collaborate … Read more

First Results with Erdafitinib-Releasing Intravesical Delivery System (TAR-210) Show Early Evidence of Positive Clinical Activity in Patients with Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations

Investigational TAR-210 first-in-human results highlight the potential for local sustained release of erdafitinib with a novel intravesical delivery system  Phase 1 results show a manageable safety profile with limited systemic toxicity, and early complete responses in patients with high-risk and intermediate-risk NMIBC MADRID, Oct. 22, 2023 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & … Read more

New Data from Phase 3 PAPILLON Study Show RYBREVANT® (amivantamab-vmjw) Plus Chemotherapy Resulted in 60 Percent Reduction in Risk of Disease Progression or Death in Patients with Previously Untreated EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer

Data show the potential impact of RYBREVANT® and chemotherapy combination as first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations Late-breaking data presented in a Presidential Symposium at 2023 ESMO Congress and simultaneously published in The New England Journal of Medicine MADRID, Oct. 21, 2023 /PRNewswire/ — … Read more

AMA president Ehrenfeld to address looming physician shortage at a National Press Club Newsmaker on Oct. 25

WASHINGTON, Oct. 20, 2023 /PRNewswire/ — On Wednesday, Oct. 25 at 1 p.m. the American Medical Association (AMA) President Jesse M. Ehrenfeld, MD, MPH, will address what America’s looming physician shortage means for patients and health care, and how to fix it at an NPC Newsmaker. Jesse M. Ehrenfeld, MD, MPH, was inaugurated as president … Read more